Foreword – ADHD in the scientific and political context J. K. BuitelaarA. Rothenberger ORIGINAL CONTRIBUTION Pages: i1 - i6
European clinical guidelines for hyperkinetic disorder – first upgrade E. TaylorM. DöpfnerA. Zuddas ORIGINAL CONTRIBUTION Pages: i7 - i30
EINAQ – A European educational initiative on Attention–Deficit Hyperactivity Disorder and associated problems A. RothenbergerM. DanckaertsH.-C. Steinhausen ORIGINAL CONTRIBUTION Pages: i31 - i35
ADORE – Attention–Deficit Hyperactivity Disorder Observational Research in Europe Stephen J. RalstonM. J. M. Lorenzoand the ADORE study group ORIGINAL CONTRIBUTION Pages: i36 - i42
EUNETHYDIS – Searching for valid aetiological candidates of Attention–Deficit Hyperactivity Disorder or Hyperkinetic Disorder J. Sergeant ORIGINAL CONTRIBUTION Pages: i43 - i49
Attention–Deficit Hyperactivity Disorder in the post–genomic era P. Ashersonand the IMAGE Consortium ORIGINAL CONTRIBUTION Pages: i50 - i70
Neuronal network models of ADHD – lateralization with respect to interhemispheric connectivity reconsidered Veit RoessnerT. BanaschewskiA. Rothenberger ORIGINAL CONTRIBUTION Pages: i71 - i79
Co–existing disorders in ADHD – implications for diagnosis and intervention C. GillbergI. C. GillbergL. Niklasson ORIGINAL CONTRIBUTION Pages: i80 - i92
Comparative efficacy of once–a–day extended–release methylphenidate, two–times–daily immediate–release methylphenidate, and placebo in a laboratory school setting M. DöpfnerW. D. GerberG. Lehmkuhl ORIGINAL CONTRIBUTION Pages: i93 - i101
Non–stimulant medications in the treatment of ADHD T. BanaschewskiV. RoessnerA. Rothenberger ORIGINAL CONTRIBUTION Pages: i102 - i116
Effectiveness of an adaptive multimodal treatment in children with Attention–Deficit Hyperactivity Disorder – global outcome M. DöpfnerD. BreuerG. Lehmkuhl ORIGINAL CONTRIBUTION Pages: i117 - i129
Areas for future investment in the field of ADHD: Preschoolers and clinical networks M. DöpfnerA. RothenbergerE. Sonuga-Barke ORIGINAL CONTRIBUTION Pages: i130 - i135
